These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4200340)

  • 21. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 22. Chlorophenoxyisobutyric acid derivatives and apolipoprotein B metabolism.
    Shepherd J; Packard CJ
    Monogr Atheroscler; 1985; 13():85-91. PubMed ID: 4088282
    [No Abstract]   [Full Text] [Related]  

  • 23. [Correction of hyperdyslipidemia using polyene-structure substances. Controlled clinical trial].
    Pagliano FM
    Arch Sci Med (Torino); 1979; 136(2):303-8. PubMed ID: 391176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
    Gustafson A
    Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
    [No Abstract]   [Full Text] [Related]  

  • 25. Altering lipid patterns in adult males.
    Appelbaum JJ; Amundsen MA; Perkin DK
    J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolic spectrum of halofenate.
    Ryan JR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):239-43. PubMed ID: 51838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
    Dujovne CA; Azarnoff DL; Pentikainen P; Manion CV; Hurwitz A
    Am J Med Sci; 1979; 277(3):255-61. PubMed ID: 222145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long term treatment with hydrophilic colloid on serum lipids.
    Danielsson A; Ek B; Nyhlin H; Steen L
    Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):148-53. PubMed ID: 111460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative study of several hypolipidemic agents related to clofibrate.
    Beaumont V; Buxtorf JC; Jacotot B; Beaumont JL
    Atherosclerosis; 1974; 20(2):141-53. PubMed ID: 4369878
    [No Abstract]   [Full Text] [Related]  

  • 32. A physician's guide to hyperlipidemia.
    Fredrickson DS
    Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum cholesterol and triglycerides.
    Myant NB
    Practitioner; 1973 Aug; 211(262):188-92. PubMed ID: 4728419
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
    Aubry F; Lapierre YL; Noël C; Davignon J
    Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
    Keller C; Wolfram G; Zöllner N
    Arzneimittelforschung; 1976; 26(12):2221-4. PubMed ID: 798591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of hyperlipoproteinemia in relation to recent classifications].
    Cloarec M
    Minerva Med; 1971 Sep; 62(72):3452-5. PubMed ID: 5097215
    [No Abstract]   [Full Text] [Related]  

  • 37. [Does magnesium-orotate improve the effect of lipid lowering drugs?].
    Irsigler K; Flegel U; Kühn P; Schubert H; Iván E; Biro L; Székely L
    Int J Clin Pharmacol; 1973 Aug; 8(1):85-95. PubMed ID: 4727450
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
    Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
    Vogelberg KH; Althoff B; Heggen EM; Thesseling W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():832-5. PubMed ID: 196437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.